EVH vs. WSC, LIF, QBTS, STNE, FTDR, GLOB, HRI, RELY, CNXC, and CARG
Should you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include WillScot (WSC), Life360 (LIF), D-Wave Quantum (QBTS), StoneCo (STNE), Frontdoor (FTDR), Globant (GLOB), Herc (HRI), Remitly Global (RELY), Concentrix (CNXC), and CarGurus (CARG). These companies are all part of the "business services" industry.
Evolent Health vs. Its Competitors
Evolent Health (NYSE:EVH) and WillScot (NASDAQ:WSC) are both business services companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.
Evolent Health has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500. Comparatively, WillScot has a beta of 1.24, suggesting that its share price is 24% more volatile than the S&P 500.
WillScot has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than WillScot, indicating that it is currently the more affordable of the two stocks.
In the previous week, Evolent Health had 1 more articles in the media than WillScot. MarketBeat recorded 8 mentions for Evolent Health and 7 mentions for WillScot. WillScot's average media sentiment score of 1.48 beat Evolent Health's score of 0.34 indicating that WillScot is being referred to more favorably in the news media.
Evolent Health presently has a consensus target price of $17.79, indicating a potential upside of 59.37%. WillScot has a consensus target price of $40.63, indicating a potential upside of 33.63%. Given Evolent Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Evolent Health is more favorable than WillScot.
95.8% of WillScot shares are owned by institutional investors. 1.4% of Evolent Health shares are owned by insiders. Comparatively, 3.1% of WillScot shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
WillScot has a net margin of 0.63% compared to Evolent Health's net margin of -4.54%. WillScot's return on equity of 26.28% beat Evolent Health's return on equity.
Summary
WillScot beats Evolent Health on 11 of the 17 factors compared between the two stocks.
Get Evolent Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evolent Health Competitors List
Related Companies and Tools
This page (NYSE:EVH) was last updated on 7/12/2025 by MarketBeat.com Staff
